These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 23658379

  • 1. Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.
    Marignier R, Bernard-Valnet R, Giraudon P, Collongues N, Papeix C, Zéphir H, Cavillon G, Rogemond V, Casey R, Frangoulis B, De Sèze J, Vukusic S, Honnorat J, Confavreux C, NOMADMUS Study Group.
    Neurology; 2013 Jun 11; 80(24):2194-200. PubMed ID: 23658379
    [Abstract] [Full Text] [Related]

  • 2. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, Küker W, Chandratre S, Vincent A, Palace J.
    JAMA Neurol; 2014 Mar 11; 71(3):276-83. PubMed ID: 24425068
    [Abstract] [Full Text] [Related]

  • 3. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.
    Kim W, Lee JE, Li XF, Kim SH, Han BG, Lee BI, Kim JK, Choi K, Kim HJ.
    Mult Scler; 2012 May 11; 18(5):578-86. PubMed ID: 21965418
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.
    Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP.
    J Neurol Sci; 2010 Apr 15; 291(1-2):52-6. PubMed ID: 20117794
    [Abstract] [Full Text] [Related]

  • 7. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
    Sato DK, Nakashima I, Takahashi T, Misu T, Waters P, Kuroda H, Nishiyama S, Suzuki C, Takai Y, Fujihara K, Itoyama Y, Aoki M.
    Neurology; 2013 Jun 11; 80(24):2210-6. PubMed ID: 23677744
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Testing for antibodies to human aquaporin-4 by ELISA: sensitivity, specificity, and direct comparison with immunohistochemistry.
    Jarius S, Franciotta D, Paul F, Bergamaschi R, Rommer PS, Ruprecht K, Ringelstein M, Aktas O, Kristoferitsch W, Wildemann B.
    J Neurol Sci; 2012 Sep 15; 320(1-2):32-7. PubMed ID: 22705047
    [Abstract] [Full Text] [Related]

  • 10. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
    Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F.
    PLoS Med; 2007 Apr 15; 4(4):e133. PubMed ID: 17439296
    [Abstract] [Full Text] [Related]

  • 11. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
    Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W.
    Brain; 2008 Nov 15; 131(Pt 11):3072-80. PubMed ID: 18945724
    [Abstract] [Full Text] [Related]

  • 12. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.
    Brain; 2007 May 15; 130(Pt 5):1235-43. PubMed ID: 17449477
    [Abstract] [Full Text] [Related]

  • 13. [Seroprevalence and diagnostic value of aquaporin-4 antibody in patients with inflammatory central nervous system demyelinating diseases].
    Wu L, Yang Y, Huang DH, Wu WP.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb 15; 31(2):350-2. PubMed ID: 21354891
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
    Jarius S, Jacobi C, de Seze J, Zephir H, Paul F, Franciotta D, Rommer P, Mader S, Kleiter I, Reindl M, Akman-Demir G, Seifert-Held T, Kristoferitsch W, Melms A, Wandinger KP, Wildemann B.
    Mult Scler; 2011 Sep 15; 17(9):1067-73. PubMed ID: 21543553
    [Abstract] [Full Text] [Related]

  • 16. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients.
    Ketelslegers IA, Modderman PW, Vennegoor A, Killestein J, Hamann D, Hintzen RQ.
    Mult Scler; 2011 Dec 15; 17(12):1527-30. PubMed ID: 21828202
    [Abstract] [Full Text] [Related]

  • 17. Combined screening for serum anti-nuclear and anti-aquaporin-4 antibodies improves diagnostic accuracy for distinguishing neuromyelitis optica from multiple sclerosis.
    Wu L, Huang D, Yang Y, Wu W.
    Eur Neurol; 2014 Dec 15; 72(1-2):103-8. PubMed ID: 24993096
    [Abstract] [Full Text] [Related]

  • 18. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.
    Arch Neurol; 2009 Sep 15; 66(9):1164-7. PubMed ID: 19752309
    [Abstract] [Full Text] [Related]

  • 19. Neuromyelitis optica antibodies in patients with severe optic neuritis in China.
    Lai C, Tian G, Takahashi T, Liu W, Yang L, Zhang X.
    J Neuroophthalmol; 2011 Mar 15; 31(1):16-9. PubMed ID: 21150455
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B.
    J Neurol Sci; 2011 Jul 15; 306(1-2):82-90. PubMed ID: 21550068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.